{"name":"Université Catholique de Louvain","slug":"universit-catholique-de-louvain","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Infliximab, methylprednisolone, methotrexate","genericName":"Infliximab, methylprednisolone, methotrexate","slug":"infliximab-methylprednisolone-methotrexate","indication":"Rheumatoid arthritis","status":"marketed"},{"name":"Methotrexate + Infliximab","genericName":"Methotrexate + Infliximab","slug":"methotrexate-infliximab","indication":"Rheumatoid arthritis","status":"marketed"},{"name":"Methotrexate + Methylprednisolone","genericName":"Methotrexate + Methylprednisolone","slug":"methotrexate-methylprednisolone","indication":"Rheumatoid arthritis","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bisphosphonate treatment","genericName":"Bisphosphonate treatment","slug":"bisphosphonate-treatment","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Bisphosphonate treatment","genericName":"Bisphosphonate treatment","slug":"bisphosphonate-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Infliximab, methylprednisolone, methotrexate","genericName":"Infliximab, methylprednisolone, methotrexate","slug":"infliximab-methylprednisolone-methotrexate","phase":"marketed","mechanism":"This combination suppresses TNF-α signaling and T-cell proliferation to reduce inflammatory immune responses in autoimmune diseases.","indications":["Rheumatoid arthritis","Crohn's disease","Ulcerative colitis","Ankylosing spondylitis","Psoriatic arthritis"],"catalyst":""},{"name":"Methotrexate + Infliximab","genericName":"Methotrexate + Infliximab","slug":"methotrexate-infliximab","phase":"marketed","mechanism":"Methotrexate suppresses immune cell proliferation while infliximab blocks tumor necrosis factor-alpha, together reducing inflammatory and autoimmune responses.","indications":["Rheumatoid arthritis","Crohn's disease","Ulcerative colitis","Ankylosing spondylitis","Psoriatic arthritis"],"catalyst":""},{"name":"Methotrexate + Methylprednisolone","genericName":"Methotrexate + Methylprednisolone","slug":"methotrexate-methylprednisolone","phase":"marketed","mechanism":"Methotrexate inhibits dihydrofolate reductase to suppress cell proliferation and immune activation, while methylprednisolone provides corticosteroid-mediated anti-inflammatory and immunosuppressive effects.","indications":["Rheumatoid arthritis","Autoimmune inflammatory conditions","Vasculitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNSHRjOE80enZ6QTQ5d0Y1NXdxMzg3TTJDX1c3ZC1MWFVrUEhFREpoWW40NGVnS09qREs5ODI4aFN1UG8tTmx2SUJaZGYyb1BfWnduLVhiR0ZRb2s5Mm45M1V5TlFncGduS0thRXJBSzQ1R3F3aUNwZlJ6MGVyc3RFYjNMbnBNcjBIcl9QdVhR?oc=5","date":"2026-01-19","type":"pipeline","source":"Frontiers","summary":"Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education - Frontiers","headline":"Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPTTltQ0VMV3doOC1UZVp4cUdic3ptNkJOUENIMF9zdXBlYjZZTjdxYnNMOXdJQktRNnNVTGlaN0xpZld3eTJ1TmJGZlpkU2RNVmlWM1ZfdkdwTktUODItRmpta1hNSjM1MlRLMU8tOFZwNU1GOE1XaExDOGhQVHI2clJNc19JLWM2NEY0VGRJSm5janpM?oc=5","date":"2025-12-23","type":"pipeline","source":"Frontiers","summary":"Editorial: Genomic discoveries and pharmaceutical development in urologic tumors - volume II - Frontiers","headline":"Editorial: Genomic discoveries and pharmaceutical development in urologic tumors - volume II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNVUycW1weTBvQklFQXhnb2tHSTl6cnh1NVBvdkI2bnRsNnF6NmJDVHljczdSVXpIaUE5cW92SjJuWUxoa0lRZHBqVDRyMHVDaGs4ZXZwRUtEdE5qcFJ3bnRQbVdNUnhiZlBlV1ZLbW5MWVN5XzVualVIU2tuYzBBRnZGdkNybUN6cWZReFFDM19LRE5jUmJnZW9B?oc=5","date":"2025-10-24","type":"trial","source":"Frontiers","summary":"Implementation of Medication Review Type 2a in Community Pharmacies: A Longitudinal Survey Study - Frontiers","headline":"Implementation of Medication Review Type 2a in Community Pharmacies: A Longitudinal Survey Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9pUjQ1UXhuQlBVQTlVNGJNcjV3WC1FQnF5VVJ5WWNwbV95OGdPU3FiZ09tLTg2dy1HVlFXZTJ4Tnpra1JHb0RxVFNFc1gzZWpJM2poX2pGQ3NRdEpLeXFuRVQzMXFlc04zbGpWUGV3QXowQm5UOWZ4elM4U1FjeTA?oc=5","date":"2025-09-30","type":"pipeline","source":"uclouvain.be","summary":"QS World ranking - uclouvain.be","headline":"QS World ranking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRVVjRWRybkZMMjFzZGtEZE1Pd2ZYVjBwQjBaZFJJdlVxdHJxZU1BaXY3aGJSRjNER3hzWm9FaE5FdlJmUXBhWmlEeXQ0NXRCTHRFR2RxQV9mS3FZTzdLUmVzZG5SU05mMXY5eEk5U1NTOGZETDJDbm9oQVVGTkNjeG85YkUteUUwSm94ZWVKb3lldE10VklTZ3B1cEtCcFJKd1NpYVNhb3VIUzQ?oc=5","date":"2025-08-14","type":"pipeline","source":"European Medical Journal","summary":"Paradigm Changes in Prostate Cancer Management in Recent Years - European Medical Journal","headline":"Paradigm Changes in Prostate Cancer Management in Recent Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQSWpOXzRZUHJLV19NcVFRbGNDWFkyamc4Nkk2MUVXRXRqRHZrUEMzWGdhY1VBRm5RbXlBQXk1dDR4dFlyMUg4eEt1czNZTk5UU2ZWWU92UUN0eHU5N1FHeEt6aDQtYmh1WXpYdF9RazhhSXlYMlVyenQzbXQ4TjJDOUFB?oc=5","date":"2025-05-26","type":"pipeline","source":"Gut Microbiota for Health","summary":"Gut microbiota and weight management: What do we know and what should we do about it? - Gut Microbiota for Health","headline":"Gut microbiota and weight management: What do we know and what should we do about it?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNaVMxZDh5Y3RHLVdWSW1rRXh3Rm84UklDcjRvNVk2RUl0dXFFT0FoV0VqNDYzQ3EwdmVuLWFrZHRmNDJIbWNhblp0Y2pGWU1BVlNpd19sbHEyNXR3OXc0cFFNVVRZa2JQcGhCZUpqTVVWWlVzTkFiUlBFWWJIWE1jNV9oeWVpSlF5ekM3dHhuTVRoX0dUdWM4Uk5lOHpPVWNWWDAxcHI0RFg0QzdGdWU5VlVCb2N3WnZqcmFpcm1FMk9pZnFyWXg4UWluVWUwd0M3RFFENVF0ZVczY0gzRFJRcko3aXA5REdobEstZ1ZlZ21BZlNsU3JRUUpVRzF2b2FyVmpiTnBZbkFOSzJYdUdFczhCR1lDN3d5alFOVzRUal83TDdMU2NmNkhIcDYzb00?oc=5","date":"2024-01-17","type":"deal","source":"businesswire.com","summary":"PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project - businesswire.com","headline":"PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOWFRac0xGZ0hZR2dxX3EyY0lDNUtlaUpPTEp3SWxZSDFzcHFYWlMxN1l5R3oySjU2YjhZOFdiejFzLXVENkg2R3JmVGVOZTRvUHBnUjl2NVVQRlEtWTRiWUdJbFdKRXloRFF3SndtZnRhTHl4ZFdYM2dlOGtJMjJhbGxjZGJCM20xSkhEdGYwMExzZUo5dmoyZXY3Z0s1SXJMSUVZVnBNTGtoWTYxMGxScGYyMEp4WDdKSUpFd1ZfS0c5ZXc?oc=5","date":"2023-02-16","type":"pipeline","source":"European Pharmaceutical Review","summary":"European Commission awards €7.7 million to mechanochemistry project - European Pharmaceutical Review","headline":"European Commission awards €7.7 million to mechanochemistry project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE4xaUNSWk9fR084OHJDNTNieHJtMFJSa2MzYldoTFRoQ2lETndNYmpEVnlxTzYxdmItRUcxZzJaSlFOcFBKdFhzQWhJeXg1Rl8xRVYwd3F3a3lNZHAwZkNSMUw1VHhoOXJyY0FZM0NLOG9Dam8?oc=5","date":"2021-01-28","type":"pipeline","source":"British Pharmacological Society | Journals","summary":"BPS Publications - British Pharmacological Society | Journals","headline":"BPS Publications - British Pharmacological Society | Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE50dm9IYUxxSExVRG9rV0V2dElIZlNmMy1wT2Q4UHVqV1FEdlVlU0Z6T3Q4SVZfUlpKU1hscE45clplUHoyZ091MHBHWjdUcURKdkJjMUo1QlpHX1Z5RU9B?oc=5","date":"2020-09-02","type":"pipeline","source":"Nature","summary":"BioWin—driving cancer immunotherapy in Wallonia - Nature","headline":"BioWin—driving cancer immunotherapy in Wallonia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE15TTZJUjBJYkRGRkhBMzgzSk1hTVF0NTVCV05QTWI2WWhuS1Q2T2NoZTdXa2J0aHVrNU0xMGpSM1NUTHFBTWpVTmdFbE9xYnZXZzZWLTF0MnFHSUg4WllNRmJn?oc=5","date":"2020-02-18","type":"pipeline","source":"ACS Publications","summary":"Kolbe Anodic Decarboxylation as a Green Way To Access 2-Pyrrolidinones - ACS Publications","headline":"Kolbe Anodic Decarboxylation as a Green Way To Access 2-Pyrrolidinones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNRGxTRE9oR29lS0lsOVltQkpEbDB4dDRHRzFoVk1BdDdSak9mLWlBeUhiNDFGQlNqVTZhZGE2M1JPQUQwWmpKcTVWdzlWVnFrVlVXZVRpSTQ5N2tCa2szbk1SU2ZpZ3UyZlZQZ1lHVjBrTDVIQnBsdl8zd083VGlaZml5TV9tcTkyanFFcUplQ0pYeW5zTktDMEFwVGRYcFcxMllTNEpaeWVWZw?oc=5","date":"2019-09-09","type":"pipeline","source":"The Conversation","summary":"Ebola in the Congo: a forgotten conflict became a danger to world health - The Conversation","headline":"Ebola in the Congo: a forgotten conflict became a danger to world health","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}